Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Vaccines Efficacy and Safety”

235 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 235 results

Early research (Phase 1)Study completedNCT03357263
What this trial is testing

Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults

Who this might be right for
Influenza, Human
Green Cross Corporation 40
Testing effectiveness (Phase 2)UnknownNCT04298060
What this trial is testing

DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)

Who this might be right for
Influenza InfectionSAD-RV Infection and COVID-19
Ansun Biopharma, Inc. 280
Post-approval studies (Phase 4)UnknownNCT01967368
What this trial is testing

Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults

Who this might be right for
Influenza, Human
The University of Hong Kong 100
Post-approval studies (Phase 4)Study completedNCT02067117
What this trial is testing

Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration.

Who this might be right for
Prevention of Influenza
Green Cross Corporation 1,139
Large-scale testing (Phase 3)Study completedNCT03165617
What this trial is testing

Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age

Who this might be right for
Influenza, Human
Seqirus 4,514
Large-scale testing (Phase 3)Ended earlyNCT04544267
What this trial is testing

Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07113392
What this trial is testing

Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for Suspension

Who this might be right for
Influenza
Jiangxi Kvvit Pharmaceutical Co., Ltd. 144
Large-scale testing (Phase 3)Study completedNCT00192400
What this trial is testing

Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.

Who this might be right for
Healthy
MedImmune LLC 2,160
Testing effectiveness (Phase 2)Study completedNCT01010737
What this trial is testing

A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly Volunteers

Who this might be right for
Influenza
BiondVax Pharmaceuticals ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00978120
What this trial is testing

Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma

Who this might be right for
H1N1 Influenza Virus
National Institute of Allergy and Infectious Diseases (NIAID) 390
Testing effectiveness (Phase 2)Study completedNCT03682120
What this trial is testing

Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 372
Large-scale testing (Phase 3)Study completedNCT05269290
What this trial is testing

Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections

Who this might be right for
Influenza, HumanAcute Respiratory InfectionCommon Cold
Valenta Pharm JSC 240
Not applicableStudy completedNCT01304563
What this trial is testing

2010/2011 Trivalent Influenza Vaccination

Who this might be right for
Influenza
The University of Hong Kong 240
Testing effectiveness (Phase 2)Study completedNCT01980966
What this trial is testing

MHAA4549A in Healthy Volunteers in an Influenza Challenge Model

Who this might be right for
Healthy Volunteer
Genentech, Inc. 101
Large-scale testing (Phase 3)Study completedNCT04682444
What this trial is testing

Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.

Who this might be right for
Acute Respiratory Viral InfectionsHuman Influenza
Joint Stock Company "Farmak" 100
Large-scale testing (Phase 3)Study completedNCT02026349
What this trial is testing

Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316

Who this might be right for
Influenza
MDVI, LLC 860
Large-scale testing (Phase 3)Ended earlyNCT03376321
What this trial is testing

Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection

Who this might be right for
Influenza A
Janssen Research & Development, LLC 334
Large-scale testing (Phase 3)Study completedNCT03189537
What this trial is testing

Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections

Who this might be right for
Influenza, HumanAcute Respiratory InfectionCommon Cold+2 more
Valenta Pharm JSC 400
Testing effectiveness (Phase 2)Study completedNCT01068912
What this trial is testing

Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza

Who this might be right for
Influenza
MDVI, LLC 530
Testing effectiveness (Phase 2)Study completedNCT04850898
What this trial is testing

Study of SAB-176 in Healthy Adult Participants

Who this might be right for
Influenza A H1N1
SAb Biotherapeutics, Inc. 62
Next Page